Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119360035> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3119360035 abstract "Background: Doxorubicin is an effective chemotherapeutic drug that commonly induce pathological alteration in skeletal muscles. Bone- marrow mesenchymal stem cells (BMMSCs) offer a therapeutic potential for tissue repair and regeneration. Tumour necrosis factor-alpha (TNF-α) and Interleukin-1 beta (IL-1β) display worthy biomarkers for tissue damage and repair. Objectives: The aim of the current study was to evaluate the therapeutic effect of BMMSCs on doxorubicin - induced skeletal myopathy in experimental animals, through histological studies, antioxidant activity and investigation of TNF-α, IL-1β as diagnostic parameters for muscle damage and regeneration. Methodology: 40 adult albino-rats were divided into 4 equal groups; Group-I (control group) injected with phosphate-buffered saline (PBS), Group-II: doxorubicin- induced myopathy model group; received no treatment, Group-III: doxorubicin- induced myopathy model left for spontaneous muscle recovery, and Group-IV: doxorubicin- induced myopathy treated with systemic BMMSCs. The skeletal muscle regeneration evaluated through histological and antioxidant activity studies and investigation of TNF-α, IL-1β and vascular endothelial growth factor (VEGF) levels. Results: Photomicrographic studies of the muscle fibers showed a more evident regeneration in MSCs treated groups (IV) when compared with the other groups received no treatment. A significant reduced levels of TNF-α, IL-1β, and increased both VEGF and antioxidant activity were demonstrated in group IV when compared with the other groups received no treatment. Conclusion: MSCs is a promising therapy for doxorubicin-induced skeletal myopathy. TNF-α, and IL-1β are helpful biomarkers for evaluation of SCs therapeutic efficacy." @default.
- W3119360035 created "2021-01-18" @default.
- W3119360035 creator A5001865270 @default.
- W3119360035 creator A5002379653 @default.
- W3119360035 creator A5036324309 @default.
- W3119360035 creator A5058578609 @default.
- W3119360035 creator A5086175967 @default.
- W3119360035 date "2020-10-01" @default.
- W3119360035 modified "2023-09-25" @default.
- W3119360035 title "Assessment of Therapeutic Efficacy of Mesenchymal Stem Cells in Doxorubicin- Induced Skeletal Myopathy: A histological and Immunological Experimental Study" @default.
- W3119360035 doi "https://doi.org/10.51429/ejmm29405" @default.
- W3119360035 hasPublicationYear "2020" @default.
- W3119360035 type Work @default.
- W3119360035 sameAs 3119360035 @default.
- W3119360035 citedByCount "0" @default.
- W3119360035 crossrefType "journal-article" @default.
- W3119360035 hasAuthorship W3119360035A5001865270 @default.
- W3119360035 hasAuthorship W3119360035A5002379653 @default.
- W3119360035 hasAuthorship W3119360035A5036324309 @default.
- W3119360035 hasAuthorship W3119360035A5058578609 @default.
- W3119360035 hasAuthorship W3119360035A5086175967 @default.
- W3119360035 hasConcept C102652120 @default.
- W3119360035 hasConcept C126322002 @default.
- W3119360035 hasConcept C142724271 @default.
- W3119360035 hasConcept C167734588 @default.
- W3119360035 hasConcept C171056886 @default.
- W3119360035 hasConcept C17991360 @default.
- W3119360035 hasConcept C198826908 @default.
- W3119360035 hasConcept C2776694085 @default.
- W3119360035 hasConcept C2777025900 @default.
- W3119360035 hasConcept C2777300911 @default.
- W3119360035 hasConcept C2779959927 @default.
- W3119360035 hasConcept C2781303535 @default.
- W3119360035 hasConcept C502942594 @default.
- W3119360035 hasConcept C503630168 @default.
- W3119360035 hasConcept C71924100 @default.
- W3119360035 hasConcept C86803240 @default.
- W3119360035 hasConcept C95444343 @default.
- W3119360035 hasConcept C98274493 @default.
- W3119360035 hasConceptScore W3119360035C102652120 @default.
- W3119360035 hasConceptScore W3119360035C126322002 @default.
- W3119360035 hasConceptScore W3119360035C142724271 @default.
- W3119360035 hasConceptScore W3119360035C167734588 @default.
- W3119360035 hasConceptScore W3119360035C171056886 @default.
- W3119360035 hasConceptScore W3119360035C17991360 @default.
- W3119360035 hasConceptScore W3119360035C198826908 @default.
- W3119360035 hasConceptScore W3119360035C2776694085 @default.
- W3119360035 hasConceptScore W3119360035C2777025900 @default.
- W3119360035 hasConceptScore W3119360035C2777300911 @default.
- W3119360035 hasConceptScore W3119360035C2779959927 @default.
- W3119360035 hasConceptScore W3119360035C2781303535 @default.
- W3119360035 hasConceptScore W3119360035C502942594 @default.
- W3119360035 hasConceptScore W3119360035C503630168 @default.
- W3119360035 hasConceptScore W3119360035C71924100 @default.
- W3119360035 hasConceptScore W3119360035C86803240 @default.
- W3119360035 hasConceptScore W3119360035C95444343 @default.
- W3119360035 hasConceptScore W3119360035C98274493 @default.
- W3119360035 hasLocation W31193600351 @default.
- W3119360035 hasOpenAccess W3119360035 @default.
- W3119360035 hasPrimaryLocation W31193600351 @default.
- W3119360035 hasRelatedWork W11341829 @default.
- W3119360035 hasRelatedWork W12471079 @default.
- W3119360035 hasRelatedWork W12861561 @default.
- W3119360035 hasRelatedWork W14741089 @default.
- W3119360035 hasRelatedWork W17349103 @default.
- W3119360035 hasRelatedWork W19209008 @default.
- W3119360035 hasRelatedWork W6369126 @default.
- W3119360035 hasRelatedWork W8561166 @default.
- W3119360035 hasRelatedWork W9617267 @default.
- W3119360035 hasRelatedWork W634513 @default.
- W3119360035 isParatext "false" @default.
- W3119360035 isRetracted "false" @default.
- W3119360035 magId "3119360035" @default.
- W3119360035 workType "article" @default.